ABBOTT LABORATORIES — Director's Dealing 2021

Aug 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2021-08-17

Reporting Person: Wainer Andrea F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-17	Common shares without par value	M	4500	$47	Acquired	54282	Direct
2021-08-17	Common shares without par value	M	10000	$38.40	Acquired	64282	Direct
2021-08-17	Common shares without par value	S	14500	$125	Disposed	49782	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-17	Option (right to buy)	$47	M	4500	Disposed	2025-02-19	Common Shares (4500)	Direct
2021-08-17	Option (right to buy)	$38.40	M	10000	Disposed	2026-02-18	Common Shares (10000)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.